Select a language:

Links / Resources

Description Click icon to view file
An Official ATS Statement: Hepatotoxicity of Antituberculosis Therapy
American Thoracic Society
acrobat-sm
California TB Risk Assessments IEicon-small
Confidential Morbidity Report – Tuberculosis
County of Orange, Health Care Agency, Public Health Services
Confidential Morbidity Report - Tuberculosis
Diagnosis of Tuberculosis in Adults and Children, 2017 Guidelines
American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America
IEicon-small
Diagnostic Standards and Classification of Tuberculosis in Adults and Children
American Thoracic Society
acrobat-sm
Drug-Resistant Tuberculosis: A Survival Guide for Clinicians, 3rd Edition
Curry International Tuberculosis Center
IEicon-small
Interferon Gamma Release Assays (IGRA's)
Centers for Disease Control & Prevention
IEicon-small
Latent Tuberculosis Infection: A Guide for Primary Healthcare Providers
Centers for Disease Control & Prevention
acrobat-sm
Managing Drug Interactions in the Treatment of HIV-Related Tuberculosis
Centers for Disease Control & Prevention
acrobat-sm
Sample LTBI Treatment Record Book acrobat-sm
Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection
Centers for Disease Control & Prevention, MMWR; vol. 49/No. RR-6
IEicon-small
Three Months Once Weekly Isoniazid Plus Rifapentine (3HP) Trifold Pamphlet acrobat-sm
Treatment of Tuberculosis
American Thoracic Society
acrobat-sm
Treatment of Drug-Susceptible Tuberculosis, 2016 Guidelines
American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America
IEicon-small